Bio-Rad Labs Inc. A buy UBS Group AG
Start price
07.12.23
/
50%
€285.60
Target price
07.12.24
€365.97
Performance (%)
8.65%
End price
08.12.24
€310.30
Summary
This prediction ended on 08.12.24 with a price of €310.30. The BUY prediction by UBS_Group_AG finished with a performance of 8.65%. UBS_Group_AG has a follow-up prediction for Bio-Rad Labs Inc. A where he still thinks Bio-Rad Labs Inc. A is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bio-Rad Labs Inc. A | -3.677% | -3.677% | -20.215% |
| iShares Core DAX® | -1.875% | 2.861% | 18.863% |
| iShares Nasdaq 100 | -2.177% | 0.048% | 3.956% |
| iShares Nikkei 225® | -0.867% | 6.987% | 21.062% |
| iShares S&P 500 | -1.253% | 1.248% | 2.246% |
Comments by UBS_Group_AG for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $395.00 price target on the stock.
Ratings data for BIO provided by MarketBeat
In the thread Trading Bio-Rad Labs Inc. A
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€205.90
03.05.25
03.05.25
€274.38
03.05.26
03.05.26
28.80%
14:06
14:06
Stopped prediction by UBS_Group_AG for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€248.20
08.05.24
08.05.24
€357.93
08.05.25
08.05.25
-12.97%
09.05.25
09.05.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€316.20
16.02.24
16.02.24
€389.51
16.02.25
16.02.25
-15.75%
17.02.25
17.02.25